These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 480779)

  • 1. [A study on therapeutic effects of enviomycin in retreatment for drug resistant pulmonary tuberculosis (author's transl)].
    Kondo K; Kuze A; Sato S; Kurematu S; Tateno S; Shimizu T; Arima J; Yamamoto KI; Obara H; Hiraga H; Takada N; Kon Y; Takagi H; Kakinoki H; Mituka M; Ueda S; Takayama K; Ueda N; Kuwajima T; Sakai Y; Hamano E; Aikawa K; Hasegawa S; Abe M; Tanaka M; Yokoyama Y; Suzuki A
    Kekkaku; 1979 May; 54(5):303-8. PubMed ID: 480779
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study on therapeutic effect of enviomycin (tuberactin) in retreatment for pulmonary tuberculosis (author's transl)].
    Yamamoto K; Aizawa H; Inoue I; Nagai S; Yamazaki M; Konishiike J; Kitatani F; Asahi T; Bessho M; Mitsufuji Y; Nakata S; Sugihara F; Tatsumi N; Kobayashi M; Matsutani Y; Yuba M; Okamoto S; Tsujimoto T; Yamaguchi S; Iwai K; Iwata S; Fukui S; Sawai A; Watanabe Y; Kakuno J; Nishizawa N
    Kekkaku; 1978 Feb; 53(2):107-113. PubMed ID: 633702
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of enviomycin (EVM) in pulmonary tuberculosis (author's transl)].
    Kuramitsu I; Ando K; Ito N; Kishimoto K; Murase Y; Matsumura H; Matsui O; Miki S; Ito T; Yanagawa T; Tanaka S; Sakai M; Takeuchi J; Yamamoto Y; Suzuki S; Sata K; Ohbori K; Horie E; Sakurai K; Mori T; Nagami T; Adachi S; Oda T; Yamaguchi K; Takehisa R
    Kekkaku; 1978 Apr; 53(4):269-73. PubMed ID: 661060
    [No Abstract]   [Full Text] [Related]  

  • 4. [A clinical study of enviomycin (EVM) for pulmonary tuberculosis and a case report of lung autopsy treated originally with EVM (author's transl)].
    Nakamura Y; Miyazawa K; Iguchi K; Kitahara N; Komatsu Y; Wakahara M; Koiwai N; Uehara S; Nakagawa S; Shimizu T; Hayakawa M; Chiba S; Komori T
    Kekkaku; 1978 May; 53(5):299-306. PubMed ID: 671952
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of tuberactinomycin-N (TUM-N) for severe pulmonary tuberculosis (author's transl)].
    Miwa T; Tsukamura M; Majima T; Ando Y; Kotetsu Y
    Kekkaku; 1975 Aug; 50(8):229-33. PubMed ID: 1195529
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study on tuberactinomycin-N (TUM-N) and viomycin (VM) in retreatment of pulmonary tuberculosis (author's transl)].
    Kekkaku; 1974 Jul; 49(7):207-15. PubMed ID: 4372439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse reactions of enviomycin during treatment for pulmonary tuberculosis (author's transl)].
    Miwa T; Tsukamura M; Kawase Y; Mashima T; Horie S; Seki F; Hashizume T; Hayashi S; Kondo I; Ariga F; Tanaka A; Takase K; Kawai M; Tanii Y; Matsutani I; Koketsu Y
    Kekkaku; 1980 Apr; 55(4):201-6. PubMed ID: 7392350
    [No Abstract]   [Full Text] [Related]  

  • 8. [Critical concentrations for resistances of tubercle bacilli to tuberactinomycin-N, viomycin, capreomycin, and lividomycin in patients treated with these agents (cross-resistance-relationships among resistances to aminoglucoside-antibiotics found during chemotherapy for tuberculosis) (author's transl)].
    Tsukamura M; Mizuno S; Murata H; Oshima T
    Kekkaku; 1975 May; 50(4-5):123-30. PubMed ID: 49449
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on tuberactinomycin-N. Report 3. Comparison of the effects of TUM-N and INH on experimental mouse tuberculosis (author's transl)].
    Shimizu T; Yokoyama M; Yoshida U; Onuma H; Narita A
    Kekkaku; 1977 Jan; 52(1):21-7. PubMed ID: 839648
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental and clinical study on the antituberculous activity of tuberactinomycin-N, a new antibiotic.
    Toyoara M
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():288-91. PubMed ID: 4468026
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tuberactinomycin-N (enviomycin-EVM) in the treatment of pulmonary tuberculosis (author's transl)].
    Ishikawa H; Nakashima N; Okada H; Tsutsumi T; Ishizaki T; Oka R; Oda T; Shigeno Y; Yamaguchi K; Nakatomi M; Hara K
    Kekkaku; 1981 Jul; 56(7):369-74. PubMed ID: 6276611
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison of the time of in vivo resistance development of tubercle bacilli to rifampicin, kanamycin, ethionamide, lividomycin, and enviomycin (tuberactinomycin-N) in patients with chronic cavitary tuberculosis (author's transl)].
    Tsukamura M
    Kekkaku; 1978 Oct; 53(10):495-8. PubMed ID: 102861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
    Toyohara M
    Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
    [No Abstract]   [Full Text] [Related]  

  • 14. [Original treatment of pulmonary tuberculosis by enviomycin (EVM)].
    Ogiwara S
    Kekkaku; 1987 Sep; 62(9):459-67. PubMed ID: 2828742
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary tuberculosis relapses: report on 102 cases observed between 1977 and 1981 (author's transl)].
    Lancestre G
    Poumon Coeur; 1981; 37(6):335-43. PubMed ID: 7335578
    [No Abstract]   [Full Text] [Related]  

  • 16. [Short course antituberculosis chemotherapy (author's transl)].
    Corradini A; Zamorano T; Soto L; Vicencio M; Hiriart M; Farga V
    Rev Med Chil; 1975 Apr; 103(4):247-50. PubMed ID: 1162193
    [No Abstract]   [Full Text] [Related]  

  • 17. [Short-course chemotherapy for pulmonary tuberculosis. 2. Evaluation of short-course chemotherapy in experimental murine tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1981 Jan; 56(1):17-21. PubMed ID: 7230589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic effect of Ofloxacin on intractable pulmonary tuberculosis. Chest disease cooperative study unit of National Sanatoriums in Kinki District].
    Matsumoto T; Ikeda N; Kanetsuna F; Kita N; Ueda E; Yamazaki M; Kanai K; Sirai F; Iwagaki K; Takenaka K
    Kekkaku; 1988 Jun; 63(6):469-74. PubMed ID: 3172625
    [No Abstract]   [Full Text] [Related]  

  • 19. [Side effect of enviomycin as the causative agent of the changes in serum electrolytes (author's transl)].
    Aizawa H; Hayashi H; Yamamoto N
    Kekkaku; 1980 Jan; 55(1):1-5. PubMed ID: 7366064
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary drug resistance to antitubercular drugs in patients with pulmonary tuberculosis in the years 1978-1982].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1986 Apr; 54(4):140-3. PubMed ID: 3090521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.